Article Text

Download PDFPDF

Refractory asthma in the UK: cross-sectional findings from a UK multicentre registry
  1. Liam G Heaney1,
  2. Chris E Brightling2,
  3. Andrew Menzies-Gow3,
  4. Michael Stevenson4,
  5. Rob M Niven5,
  6. on behalf of the British Thoracic Society Difficult Asthma Network
  1. 1Centre for Infection and Immunity, Queen's University of Belfast, UK
  2. 2Department of Infection, Inflammation and Immunity, Institute for Lung Health, University of Leicester, UK
  3. 3Royal Brompton Hospital, London, UK
  4. 4School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, UK
  5. 5North West Lung Centre, University of Manchester, Manchester, UK
  1. Correspondence to Dr Liam Heaney, Centre for Infection and Immunity, Queen's University of Belfast, Level 8, Belfast City Hospital, Lisburn Road, Belfast BT9 7AB, UK; l.heaney{at}


Introduction Refractory asthma represents a significant unmet clinical need where the evidence base for the assessment and therapeutic management is limited. The British Thoracic Society (BTS) Difficult Asthma Network has established an online National Registry to standardise specialist UK difficult asthma services and to facilitate research into the assessment and clinical management of difficult asthma.

Methods Data from 382 well characterised patients, who fulfilled the American Thoracic Society definition for refractory asthma attending four specialist UK centres—Royal Brompton Hospital, London, Glenfield Hospital, Leicester, University Hospital of South Manchester and Belfast City Hospital—were used to compare patient demographics, disease characteristics and healthcare utilisation.

Results Many demographic variables including gender, ethnicity and smoking prevalence were similar in UK centres and consistent with other published cohorts of refractory asthma. However, multiple demographic factors such as employment, family history, atopy prevalence, lung function, rates of hospital admission/unscheduled healthcare visits and medication usage were different from published data and significantly different between UK centres. General linear modelling with unscheduled healthcare visits, rescue oral steroids and hospital admissions as dependent variables all identified a significant association with clinical centre; different associations were identified when centre was not included as a factor.

Conclusion Whilst there are similarities in UK patients with refractory asthma consistent with other comparable published cohorts, there are also differences, which may reflect different patient populations. These differences in important population characteristics were also identified within different UK specialist centres. Pooling multicentre data on subjects with refractory asthma may miss important differences and potentially confound attempts to phenotype this population.

  • Refractory asthma
  • National registry
  • clinical assessment
  • asthma phenotypes
  • asthma epidemiology
  • asthma

This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: and

View Full Text

Statistics from


  • Funding Pilot funding for the Registry was provided as unrestricted research grants from Astra Zeneca, Glaxo Smith Kline and Novartis. CB is supported by a Wellcome Senior Clinical Fellowship.

  • Competing interests None.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.